Home » News » Study Conduct » Medpace opens new clinical pharmacology unit, expanding phase I-IIa capabilities

Medpace opens new clinical pharmacology unit, expanding phase I-IIa capabilities

Thursday, July 19, 2012

Cincinnati-based Medpace has opened the Medpace Clinical Pharmacology Unit (CPU) in Cincinnati. The new 60,000-square-foot facility is double the size of the previous unit, increasing Medpace’s ability to conduct multiple studies with a total of 96 beds for overnight stays. The facility houses a pharmacy, processing labs and a dedicated patient recruitment staff for recruitment and screening of study subjects. The new CPU joins the Medpace global headquarters and the Medpace CRO.

Medpace president Dr. August Troendle said both the Medpace Reference Laboratories (MRL) and the Medpace Bioanalytical Laboratories (MBL) will be finished at the new location by the end of the year, completing the fully integrated campus.

 

Related Posts